Besbes, Samaher <br/><br/>
The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia.  [electronic resource] 

 -  Critical reviews in oncology/hematology  Apr 2016 
 - 32-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-0461 
<br/><br/><label>Standard No.: </label>10.1016/j.critrevonc.2016.02.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aniline Compounds--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors<br/>Peptide Fragments--analysis<br/>Proto-Oncogene Proteins--analysis<br/>Sulfonamides--pharmacology